04 Jul 2019 --- Supplementation with the pasteurized form of gut-bacteria Akkermansia muciniphila (A. muciniphila) has been found to reduce cardiovascular risk factors, moderate pre-diabetes progression, as well as lower cholesterol levels in obese participants. Looking forward, researchers at the University of Louvain (UCLouvain), Belgium, are planning larger-scale tests and commercialization of the bacteria in the form of food supplements, expected for 2021. They hope that it proves helpful for the Western population where one in two people are overweight and have increased cardiovascular risks, according to the World Health Organization (WHO) data.
